NR2F6 and hepatoblastoma: Through ChIP-seq data and transcriptome analysis, the targets and molecular mechanism for NR2F6 were disclosed by GO annotation and pathway analysis, indicating that the rapid progression of residual hepatoblastoma might result from dysregulation of lipid metabolism stimulated by overexpressed NR2F6 in residual hepatoblastoma.